Skip to main content

The Wistar Institute

|

Q&A with Pratik Bhojnagarwala and Alexandra Indeglia, Organizers of Wistar’s First Trainee Research Symposium

On Friday, February 24, 2023, more than 175 postdoctoral, graduate, and undergraduate students from around Philadelphia came together for the very first Wistar Institute Trainee Research Symposium. The Symposium was developed and run by leaders of W…
|

What We Now Know About Long Covid

Dr. Luis J. Montaner and lab find common, persistent symptoms for long-haulers by reviewing a multitude of research studies. An international team of researchers led by The Wistar Institute’s lead scientist on HIV-cure research has published a revie…
|

Wistar Scientists Uses Artificial Intelligence to Identify Viruses Related to Cancer

Some cancers are linked to viral infections. Studying viruses found in tumor cells can reveal important information in the development of more effective cancer treatments. Wistar researchers developed a tool to study the expression of cancer-related…
|

The Wistar Institute and Stowers Institute for Medical Research in Kansas City Announces Friendly Super Bowl Wager between the Two Biomedical Research Institutes

MEDIA ADVISORY WHAT:The Wistar Institute and Stowers Institute for Medical Research in Kansas City Announces Friendly Super Bowl Wager between the Two Biomedical Research Institutes The Wistar Institute have made a friendly wager with Stowers Instit…
|

Wistar Scientists Identify a Gene Signature to Assess Cancer Risk

PHILADELPHIA — (FEBRUARY, 6, 2023) — In a paper published in PNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar’s Ellen and Ronald Caplan Cancer Center and Ira Brind Professor and Program Leader in the Molecular & Cellular Oncogenesis Progra…
|

Wistar Scientists Study Ferroptosis to Improve Cancer Treatments

What clues can a cell’s death reveal for immunotherapies for treating cancer and other diseases? Wistar scientists Dr. Yulia Nefedova, associate professor in the Immunology, Microenvironment & Metastasis Program in the Ellen and Ronald Caplan Ca…
|

Dr. Noam Auslander Wins Michelson Prize

The annual award supports early career investigators and their work advancing in the immunology, vaccine, and immunotherapy space. Noam Auslander, Ph.D., Assistant Professor in the Molecular & Cellular Oncogenesis Program of the Ellen and R…
|

Michael Criscuolo joins The Wistar Institute as Vice President of Development

PHILADELPHIA — (Jan. 24, 2023) — The Wistar Institute, which has recently launched a $75 million programmatic campaign investing in biomedical advances, announces the appointment of Michael Criscuolo as Vice President of Development. “We are delight…
|

Up Close with SVP of Business Development and Executive Director of Technology Transfer

Heather A. Steinman, Ph.D., M.B.A., joined The Wistar Institute as vice president for business development and executive director of technology transfer in October 2014. Dr. Steinman was hired into a newly created position to forge new strategi…
|

Wistar Institute HIV Researchers Win Grant to Explore Genetically Engineered Natural Killer Cells as HIV Therapy

PHILADELPHIA — (Jan. 19, 2023) — amfAR, The Foundation for AIDS Research, has awarded Luis J. Montaner, D.V.M., D.Phil., in collaboration with Mohamed Abdel-Mohsen, Ph.D., a Target Grant for $397,663 over two years. Montaner, who leads The Wistar In…